Generic name:alpelisib (oral route) [ al-pe-LIS-ib ]
Drug class:PI3K inhibitors
Medically reviewed by Drugs.com. Last updated on Mar 18, 2022.
Commonly used brand name(s)
In the U.S.
- Piqray 200MG Daily Dose
- Piqray 250MG Daily Dose
- Piqray 300MG Daily Dose
- Vijoice
Available Dosage Forms:
- Tablet
Therapeutic Class: Antineoplastic Agent
Uses for Piqray 200MG Daily Dose
Alpelisib is used together with other medicines (eg, fulvestrant) to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic (cancer that has spread) breast cancer in men and in women who have already stopped menstruating (postmenopausal). Your doctor will test for the presence of the mutation.
Alpelisib is also used to treat PIK3CA-related overgrowth spectrum (PROS). PROS is a group of rare conditions that cause body parts to grow too much or have an unusual shape.
Alpelisib interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be affected by the medicine, other unwanted effects will also occur. Some of these may be serious and must be reported to your doctor.
This medicine is available only with your doctor's prescription.
Before using Piqray 200MG Daily Dose
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies have not been performed on the relationship of age to the effects of alpelisib to treat breast cancer in children a...
